| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0733-8651(03)00077-8 |
| P698 | PubMed publication ID | 14621459 |
| P2093 | author name string | Sidney C Smith | |
| Jeff P Steinhoff | |||
| P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
| Primary prevention of coronary heart disease in women through diet and lifestyle | Q28140155 | ||
| Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation | Q28188284 | ||
| Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative | Q28192496 | ||
| Warfarin, aspirin, or both after myocardial infarction | Q28193836 | ||
| The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
| MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q28214393 | ||
| Adherence with statin therapy in elderly patients with and without acute coronary syndromes | Q28215528 | ||
| The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study | Q29617822 | ||
| Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | Q29618529 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels | Q29620696 | ||
| Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3. | Q30622495 | ||
| Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease | Q33611567 | ||
| Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial | Q33940282 | ||
| Effect of carvedilol on survival in severe chronic heart failure | Q33949292 | ||
| Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). | Q34164324 | ||
| Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra | Q34189543 | ||
| High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies | Q34496492 | ||
| Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
| Beta blockade during and after myocardial infarction: an overview of the randomized trials | Q34557544 | ||
| Determinants of dropout rate among hypertensive patients in an urban clinic | Q39206066 | ||
| Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? | Q40496473 | ||
| Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project | Q40518469 | ||
| Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease | Q40763495 | ||
| When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction | Q40900446 | ||
| Predictors of smoking cessation after coronary artery bypass graft surgery. Results of a randomized trial with 5-year follow-up | Q41042494 | ||
| Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid | Q42078958 | ||
| The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group | Q42556789 | ||
| Hypercholesterolemia: the current educational needs of physicians | Q43694449 | ||
| Prompting physicians for preventive procedures: a five-year study of manual and computer reminders. | Q44253943 | ||
| The effect of warfarin on mortality and reinfarction after myocardial infarction | Q44339433 | ||
| Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). | Q45208371 | ||
| A case-management system for coronary risk factor modification after acute myocardial infarction | Q46072381 | ||
| Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention | Q46602962 | ||
| Effects of chronic smoking on platelet function | Q46649738 | ||
| Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial | Q47341921 | ||
| Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. | Q51608271 | ||
| Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease. | Q51611276 | ||
| Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. | Q54205380 | ||
| Beneficial Six-Year Outcome of Smoking Cessation in Older Men and Women with Coronary Artery Disease | Q57268101 | ||
| ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary | Q58975486 | ||
| AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update | Q58975659 | ||
| Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapy | Q67925863 | ||
| An Overview of the British and American Aspirin Studies | Q68297492 | ||
| Promoting health and preventing disease in health care settings: an analysis of barriers | Q69763777 | ||
| Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction | Q70056002 | ||
| Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS Registry). Coronary Artery Surgery Study | Q71745720 | ||
| Effects of exercise on coronary atherosclerotic lesions | Q72842500 | ||
| A collaborative model for hospital-based cardiovascular secondary prevention | Q73018207 | ||
| Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee | Q73321055 | ||
| Early statin treatment following acute myocardial infarction and 1-year survival | Q73595077 | ||
| Images in cardiovascular medicine. Thromboembolism in real-time two-dimensional echocardiography | Q78757239 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 471-482 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Cardiology clinics | Q2600141 |
| P1476 | title | Putting prevention into daily practice | |
| P478 | volume | 21 |
| Q46510290 | Implementation of the patient education about cardiovascular risk factors into a daily routine of the Cardiology Unit of the hospital | cites work | P2860 |
Search more.